Bevacizumab for Newly Diagnosed Glioblastoma

Pannullo, Susan C. MD, FAANS

Associate Professor of Clinical Neurological Surgery, Director of Neuro-Oncology, Weill Cornell Medical College

Dr. Pannullo reports no financial relationships relevant to this field of study.

Neurology Alert 32(8):p 53-54, April 2014.

Synopsis:Two recent randomized, placebo-controlled clinical trials of treatment of glioblastoma multiforme with bevacizumab have not shown superiority over standard treatment.

Sources: Gilbert MR, et al. A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med 2014;270:699-708.

Chinot OL, et al. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med 2014;270:370:709-722.